RSCM

Rock Springs Capital Management Portfolio holdings

AUM $1.6B
This Quarter Return
+8.38%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$1.6B
AUM Growth
+$1.6B
Cap. Flow
-$238M
Cap. Flow %
-14.81%
Top 10 Hldgs %
36.09%
Holding
105
New
9
Increased
32
Reduced
29
Closed
12

Top Buys

1
AGIO icon
Agios Pharmaceuticals
AGIO
$21.5M
2
CAI
Caris Life Sciences, Inc. Common Stock
CAI
$21.2M
3
OMDA
Omada Health, Inc. Common Stock
OMDA
$16.8M
4
XBI icon
SPDR S&P Biotech ETF
XBI
$12.6M
5
ACLX icon
Arcellx
ACLX
$12.3M

Top Sells

1
BPMC
Blueprint Medicines
BPMC
$105M
2
NUVL icon
Nuvalent
NUVL
$25.5M
3
NBIX icon
Neurocrine Biosciences
NBIX
$23.9M
4
LEGN icon
Legend Biotech
LEGN
$17.4M
5
UNH icon
UnitedHealth
UNH
$15.6M

Sector Composition

1 Healthcare 98.9%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CGEN icon
76
Compugen
CGEN
$134M
$1.76M 0.11%
989,990
– –
SION
77
Sionna Therapeutics, Inc. Common Stock
SION
$1.09B
$1.73M 0.11%
99,429
– –
LUNG icon
78
Pulmonx
LUNG
$71.3M
$1.69M 0.11%
651,100
+147,400
+29% +$382K
NGNE icon
79
Neurogene
NGNE
$277M
$1.56M 0.1%
104,339
– –
CATX icon
80
Perspective Therapeutics
CATX
$250M
$1.53M 0.1%
444,383
– –
APLS icon
81
Apellis Pharmaceuticals
APLS
$3.58B
$1.46M 0.09%
84,300
+4,300
+5% +$74.4K
SRPT icon
82
Sarepta Therapeutics
SRPT
$1.81B
$1.17M 0.07%
68,600
-90,700
-57% -$1.55M
MRSN icon
83
Mersana Therapeutics
MRSN
$36.6M
$1.13M 0.07%
3,814,684
– –
APLT icon
84
Applied Therapeutics
APLT
$75.4M
$646K 0.04%
2,075,991
+1,100
+0.1% +$342
ADAP
85
Adaptimmune Therapeutics
ADAP
$15.4M
$595K 0.04%
2,483,468
– –
KRRO icon
86
Korro Bio
KRRO
$197M
$446K 0.03%
35,719
– –
CRL icon
87
Charles River Laboratories
CRL
$7.94B
$410K 0.03%
+2,700
New +$410K
ETNB icon
88
89bio
ETNB
$1.34B
$393K 0.02%
40,000
-804,441
-95% -$7.9M
PCVX icon
89
Vaxcyte
PCVX
$4.11B
$361K 0.02%
+11,100
New +$361K
NVAX icon
90
Novavax
NVAX
$1.22B
$340K 0.02%
53,900
-596,100
-92% -$3.76M
TLPH icon
91
Talphera
TLPH
$10.7M
$146K 0.01%
316,460
– –
NUVB.WS icon
92
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$70.1M
$36.2K ﹤0.01%
134,028
– –
BCRX icon
93
BioCryst Pharmaceuticals
BCRX
$1.76B
– –
-222,011
Closed -$1.67M
BEAM icon
94
Beam Therapeutics
BEAM
$1.66B
– –
-150,020
Closed -$2.93M
INZY
95
DELISTED
Inozyme Pharma
INZY
– –
-3,445,299
Closed -$3.14M
LEGN icon
96
Legend Biotech
LEGN
$6.38B
– –
-512,932
Closed -$17.4M
MGNX icon
97
MacroGenics
MGNX
$113M
– –
-1,145,214
Closed -$1.45M
PLRX icon
98
Pliant Therapeutics
PLRX
$101M
– –
-589,996
Closed -$796K
SGMT icon
99
Sagimet Biosciences
SGMT
$236M
– –
-787,808
Closed -$2.57M
VIGL
100
DELISTED
Vigil Neuroscience
VIGL
– –
-471,958
Closed -$840K
1 2 3
4
5